Statistics
Publications
15
Citations
2.6K
H-Index
13
Active since
2009
Ryan R. Willard is an author at Arvinas (United States) specializing in hormonal cancer therapy, medicine, and molecular oncology.
Publications per year
2009–2024
15
15
Catalytic in vivo protein knockdown by small-molecule PROTACs
Daniel P. Bondeson, Alina Mares, Ian E. Smith et al. · Nature Chemical Biology · 2015 · 1.3K citations · Full text
Jemilat Salami, Shanique Alabi, Ryan R. Willard et al. · Communications Biology · 2018 · 346 citations · Full text
Medicine, Oncology, Pharmacology +16
ARV-110: An oral androgen receptor PROTAC degrader for prostate cancer.
Taavi K. Neklesa, Lawrence B. Snyder, Ryan R. Willard et al. · Journal of Clinical Oncology · 2019 · 207 citations
Medicine, Oncology, Pharmacology +16
Sheryl M. Gough, John J. Flanagan, Jessica L.F. Teh et al. · Clinical Cancer Research · 2024 · 160 citations · Full text
Abstract P5-04-18: ARV-471, an oral estrogen receptor PROTAC degrader for breast cancer
JJ Flanagan, Yimin Qian, SM Gough et al. · Cancer Research · 2019 · 133 citations
1–5 of 15